Dashboard
Manage Tickers

PFE PFIZER INC

NYSE pfizer.com


$ 24.68 $ 0.36 (1.48 %)    

Friday, 31-Oct-2025 17:51:31 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.12 $ 3.02 (0.48 %)
DIA $ 475.66 $ 0.66 (0.14 %)
SPY $ 682.18 $ 2.23 (0.33 %)
TLT $ 90.34 $ -0.27 (-0.3 %)
GLD $ 368.12 $ -2.01 (-0.54 %)
$ 24.65
$ 24.17
$ 24.68 x 2
$ 24.68 x 3
$ 24.16 - $ 24.73
$ 20.18 - $ 27.69
132,057,118
na
140.15B
$ 0.50
$ 13.03
TBD
na
na ($ 0.07)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-29-2025 10-Q
2 05-05-2025 03-30-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-04-2024 09-29-2024 10-Q
5 08-05-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-08-2023 10-01-2023 10-Q
9 08-09-2023 07-02-2023 10-Q
10 05-10-2023 04-02-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-09-2022 10-02-2022 10-Q
13 08-10-2022 07-03-2022 10-Q
14 05-11-2022 04-03-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-12-2021 10-03-2021 10-Q
17 08-12-2021 07-04-2021 10-Q
18 05-13-2021 04-04-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-05-2020 09-27-2020 10-Q
21 08-06-2020 06-28-2020 10-Q
22 05-07-2020 03-29-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-07-2019 09-29-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-09-2018 07-01-2018 10-Q
30 05-10-2018 04-01-2018 10-Q
31 02-22-2018 12-31-2017 10-K
32 11-09-2017 10-01-2017 10-Q
33 08-10-2017 07-02-2017 10-Q
34 05-11-2017 04-02-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-10-2016 10-02-2016 10-Q
37 08-11-2016 07-03-2016 10-Q
38 05-12-2016 04-03-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-05-2015 09-27-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Novo Nordisk Spokesperson Says "Pfizer's C...
10/31/2025 21:59:39

-Reuters

Core News & Articles
Pfizer Files Lawsuit Against Metsera, Its ...
10/31/2025 20:42:04

Pfizer Inc. today announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. i...

Core News & Articles
Pfizer Granted Early Termination Of Waitin...
10/31/2025 19:52:52

Pfizer Inc. (NYSE:PFE) today announced the U.S. Federal Trade Commission has granted early termination of the waiting period un...

eli-lilly-extends-lead-in-150b-obesity-drug-race-as-novo-pfizer-clash--heres-how-etfs-stand-to-gain
Eli Lilly Extends Lead In $150B Obesity Dr...
10/30/2025 20:04:44

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the...

Core News & Articles
'Pfizer mulls suing Metsera, Novo over top...
10/30/2025 17:38:35

https://www.semafor.com/article/10/30/2025/pfizer-mulls-suing-metsera-novo-over-topping-bid

pfizer-blasts-novo-nordisks-9-billion-counteroffer-for-metsera-as-reckless
Pfizer Blasts Novo Nordisk's $9 Billion Co...
10/30/2025 15:39:34

Novo Nordisk's $9 billion offer for Metsera challenges Pfizer's existing merger deal, prompting sharp criticism and pot...

Core News & Articles
Novo Nordisk Says Our Proposal Offers Comp...
10/30/2025 13:44:06

- Reuters 

Core News & Articles
Pfizer Deems Novo Nordisk's Metsera Propos...
10/30/2025 11:19:57

Pfizer Inc. (NYSE:PFE) is aware of the reckless and unprecedented proposal by Novo Nordisk A/S (NYSE:NVO) to acquire Metsera, I...

i-still-cant-believe-its-around-cramer-rips-plug-power
'I Still Can't Believe It's Around': Crame...
10/29/2025 11:54:36

Mad Money Lightning Round: Jim Cramer says Sempra (SRE) is a buy, supported by Wells Fargo's Overweight rating. Pfizer (PFE...

ken-paxton-alleges-johnson--johnson-misled-mothers-on-tylenol-safety
Ken Paxton Alleges Johnson & Johnson Misle...
10/28/2025 17:11:17

Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for ...

Core News & Articles
'US Fires Top Health Official Who Opposed ...
10/28/2025 12:50:58

https://www.bloomberg.com/news/articles/2025-10-28/us-fires-top-health-official-who-opposed-widely-used-covid-shots?srnd=homepa...

wellgistics-and-datavault-team-up-to-transform-prescription-tracking
Wellgistics And DataVault Team Up To Trans...
10/22/2025 12:30:33

DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market.

pfizer-canada-announces-health-canada-approval-of-abrysvo-for-adults-18-health-canada-approved-new-indication-for-abrysvo-for-use-in-adults-aged-18-59
Pfizer Canada Announces Health Canada Appr...
10/21/2025 16:04:56

With the approval of ABRYSVO® for adults aged 18+, there is now a way to help protect against RSV in a population that previous...

mark-cuban-isnt-convinced-trumprx-is-going-to-change-the-game-but-hes-giving-them-credit-for-trying
Mark Cuban Isn't Convinced TrumpRx Is Goin...
10/21/2025 05:38:41

Billionaire entrepreneur Mark Cuban offered rare praise for the Trump administration's push to lower prescription drug cost...

reported-sunday-pfizers-braftovi-plus-mektovi-delivers-476-month-median-overall-survival-in-treatment-nave-braf-v600e-mutant-lung-cancer-setting-new-long-term-benchmark
Reported Sunday, Pfizer's BRAFTOVI Plus ME...
10/20/2025 07:44:05

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients w...

Core News & Articles
Reported Sunday, Pfizer And Astellas Repor...
10/20/2025 07:41:36

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in ...

invo-fertility-stock-is-plunging-after-white-house-announcement
Invo Fertility Stock Is Plunging After Whi...
10/17/2025 18:37:05

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announceme...

uk-health-agency-recommends-gsk-backed-viiv-healthcares-apretude-as-injectable-hiv-treatment
UK Health Agency Recommends GSK-Backed Vii...
10/17/2025 16:43:32

NICE recommends ViiV Healthcare's Apretude as the first injectable PrEP for HIV prevention, offering an alternative to dail...

novo-vs-lilly-vs-pfizer-who-wins-if-trump-slashes-the-price-of-weight-loss-drugs
Novo Vs. Lilly Vs. Pfizer: Who Wins If Tru...
10/17/2025 14:19:58

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential imp...

reported-earlier-pfizer-ceo-says-us-pharma-industry-needs-to-collaborate-with-china--reuters
Reported Earlier: 'Pfizer CEO says US phar...
10/15/2025 11:43:40

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-says-us-pharma-industry-needs-collaborate-with-china-202...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION